TechGuru,

Thanks for that explanation. I assumed that was your rationale.

I was under the impression that the Severe trial included the ability of a preliminary readout of the first 50 patients after two weeks. I could be mistaken.

If, by chance, that is true, then the May 8th revision to that trial, which includes many new hospitals, might get us to 50 patients pretty quickly.

And if that is true, I was hoping that the results from the 75 patient Mild to Moderate, along with the preliminary readout of the first 50 Severe patients (after two weeks), might be enough for the FDA to not demand a P3 trial for the Mild to Moderate.

It is true that several of the new hospitals are not yet actively recruiting, but we'd at least get some visibility regarding progress at Novant Health.

New Severe Trial Hospitals

UCLA
Los Angeles, CA

Yale University
New Haven, CT

Harvard University/Beth Israel
Boston, MA

Montefiore Medical Center
Bronx, NY

University of Texas
Houston, TX

Novant Health
15 Hospitals -- Multiple States

Ohio Health
Cleveland, OH

Oregon Health and Sciences University
Portland, OR

St. Barnabas
Livingston, NJ

Atlantic Health System Hospital
Morristown, NJ

Eisenhower Health
Rancho Mirage, CA